checkAd
    Startseite > Aktien > Transgene > Nachrichten
    Transgene Aktie
    1,3740
     
    EUR
    -5,70 %
    -0,0830 EUR
    Letzter Kurs 19.04.24 Lang & Schwarz
    1,3320
     
    EUR
    846 STK
    Geldkurs 19.04.24
    1,4160
     
    EUR
    846 STK
    Briefkurs 19.04.24
    ISIN: FR0005175080 · WKN: 913048 · Frankreich

    Neueste Nachrichten

    Availability of Transgene's 2023 Universal Registration Document
    11.04.24 · globenewswire · Transgene
    Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
    09.04.24 · globenewswire · Transgene
    Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025
    27.03.24 · globenewswire · Transgene
    Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources Officer
    27.03.24 · globenewswire · Transgene
    Transgene Announces Upcoming Investor Meetings
    18.03.24 · globenewswire · Transgene
    Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024
    06.03.24 · globenewswire · Transgene
    Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
    05.03.24 · globenewswire · Transgene
    Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer
    22.01.24 · globenewswire · Transgene
    Transgene Announces Financial Calendar for 2024
    22.01.24 · globenewswire · Transgene
    Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050
    08.01.24 · globenewswire · Transgene
    Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2023
    04.01.24 · globenewswire · Transgene
    Transgene Announces Upcoming Investor Meetings
    21.12.23 · Business Wire (engl.) · Transgene